Participants 98 147 5
postmenopausal women with advanced breast cancer.
Participants 149 270 5
Eighty-eight postmenopausal women with metastatic breast cancer, in whom estrogen receptors (ER) were positive or unknown
Participants 512 568 3
Patients with known ER negative status were not studied.
Participants 1172 1223 3
postmenopausal patients with advanced breast cancer
